Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib
Oncolytic Virotherapy · 2020
DOI: 10.2147/ov.s252727 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncolytic Virotherapy, 2020. Verfasst von Laura V Ashton und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collin…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, USA.
- Departiment of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, USA.
ORCID-Profile: Laura V Ashton, Barbara Graham, Amy L MacNeill
Zitieren
APA
Ashton, L. V., Graham, B., Afzali, M. F., Gustafson, D., & MacNeill, A. L. (2020). Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib. Oncolytic Virotherapy. https://doi.org/10.2147/ov.s252727
Vancouver
Ashton LV, Graham B, Afzali MF, Gustafson D, MacNeill AL. Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib. Oncolytic Virotherapy. 2020. doi:10.2147/ov.s252727
BibTeX
@article{Ashton2020,
author = {Ashton, Laura V and Graham, Barbara and Afzali, Maryam F and Gustafson, Daniel and MacNeill, Amy L},
title = {Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib},
journal = {Oncolytic Virotherapy},
year = {2020},
doi = {10.2147/ov.s252727}
}
EUVIMED